Welcome to our dedicated page for BlackRock Science and Tech Term ord news (Ticker: BSTZ), a resource for investors and traders seeking the latest updates and insights on BlackRock Science and Tech Term ord stock.
BlackRock Science and Technology Term Trust (BSTZ) generates a steady flow of news as a closed-end management investment company focused on science and technology-related securities. Company communications and press releases highlight how the trust manages its distributions, conducts tender offers for its shares, and reports on portfolio and strategy developments within its sector focus.
News about BSTZ often centers on managed distribution plan updates. BlackRock has announced changes to the fund’s distribution methodology, including shifts to paying monthly distributions based on a rolling average net asset value and later moving from a floating rate distribution to a level rate distribution at a stated monthly rate. These updates are described as intended to enhance distribution stability, maintain a competitive distribution rate, and help manage the balance between public and private investments in the portfolio.
Another recurring theme in BSTZ news is tender offers for its common shares. BlackRock has reported on tender offers in which BSTZ offered to repurchase up to a specified percentage of its outstanding shares. These announcements detail whether the offers were oversubscribed, the pro rata allocation among tendering shareholders, and the purchase price expressed as a percentage of net asset value.
Earlier communications have also discussed BSTZ’s investment approach, including its focus on science and technology companies, the inclusion of private investments, and the use of a single-stock option-writing strategy to support monthly distributions. Investors following BSTZ news can use this page to review updates on distribution policies, capital management actions, and other official disclosures referenced in BlackRock’s press releases.
BlackRock closed‑end funds BMEZ, BSTZ, BTX announced distribution plan updates effective with the October 2025 distribution cycle (declaration 9/10/2025; ex‑date and record 10/15/2025; payable 10/31/2025). Each fund moves from a floating rate to a level monthly distribution at stated per‑share amounts: BMEZ $0.11000, BSTZ $0.16250, BTX $0.05250.
Estimated allocation data as of 8/29/2025 show large portions of recent distributions characterized as return of capital (BMEZ and BTX ~100% ROC for the reported periods; BSTZ shows long‑term gains). Reported annualized distribution rates (as of 7/31/2025) are BMEZ 13.04%, BSTZ 11.37%, BTX 12.32%. Boards may amend or suspend plans and distributions affect NAV.
BlackRock announced significant updates to the managed distribution plans for three funds: BMEZ, BSTZ, and BTX. Starting October 2025, the funds will transition from floating rate to level rate monthly distributions. The new fixed monthly distributions are: $0.11 for BMEZ, $0.1625 for BSTZ, and $0.0525 for BTX.
The changes represent decreases from prior distributions and aim to enhance distribution stability while maintaining competitive rates. For the fiscal year through August 29, 2025, BMEZ and BTX distributions were entirely return of capital, while BSTZ distributions came from long-term capital gains. The funds' performance varies significantly, with BSTZ showing positive 5-year returns of 5.85%, while BMEZ and BTX reported negative returns of -0.18% and -11.19% respectively.
BlackRock announced final results for tender offers of three closed-end funds. The offers, which expired on November 19, 2024, were oversubscribed for each fund. Each fund will purchase shares from tendering shareholders on a pro rata basis. For BlackRock Science and Technology Term Trust (BSTZ), 19,714,994 shares were tendered, with 1,854,222 to be purchased at $22.3440 per share, representing a pro-ration factor of 0.09414755. Similar results were reported for BCX and BOE funds. Payments are expected within five business days after expiration.
BlackRock announced the expiration and preliminary results of tender offers for three closed-end funds: BSTZ, BCX, and BOE. Each fund offered to repurchase up to 2.5% of its outstanding common shares. The tender offers were significantly oversubscribed, with BCX receiving 20,587,371 shares tendered against 2,056,355 shares offered for repurchase. Due to oversubscription, share purchases will be prorated. The purchase price will be 98% of each fund's NAV as of November 20, 2024.
BlackRock closed-end funds announced final results of their tender offers for up to 2.5% of outstanding common shares. The offers, which expired on August 20, 2024, were oversubscribed for each fund. As a result, shares will be purchased from all tendering shareholders on a pro rata basis. The BlackRock Science and Technology Term Trust (BSTZ) had 23,251,771 shares tendered, with 1,901,766 to be purchased at $21.4522 per share. The pro-ration factor for BSTZ is 0.08188543. Two other BlackRock funds, BCX and BOE, also reported their tender offer results. Payments for accepted shares are expected within five business days after the expiration date.
BlackRock closed-end funds BSTZ, BCX, and BOE announced the expiration and preliminary results of their tender offers for up to 2.5% of outstanding common shares. The offers, which began on July 19, 2024, and ended on August 20, 2024, were significantly oversubscribed. BSTZ offered 1,901,766 shares but received tenders for 23,251,771 shares. BCX and BOE also saw high demand, with tenders exceeding the offered amounts by over 10 times. Due to oversubscription, share purchases will be prorated. The purchase price will be 98% of each fund's NAV as of August 21, 2024. Final results, including pro-ration factors, are expected to be announced around August 21, 2024.
Summary not available.
BlackRock has released its first quarter commentary for Science and Technology Trust II (BSTZ). Since its IPO in June 2019, BSTZ has achieved a remarkable 95% return on market price, exceeding the S&P MidCap 400 Info Tech Index by 28%. In March 2021, BSTZ announced a 49% increase in its monthly distribution, now yielding an annualized rate of 5.4%. The fund currently holds 28 private investments, representing 25% of its portfolio, and indicates a strong pipeline for future investments.